Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Treatment improved some symptoms but not all.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Some new treatments for children's skin conditions are effective, but risks must be weighed.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

COVID-19 can cause various skin issues, like rashes and hair loss, which help in early diagnosis.

The patient has Chronic Cutaneous Lupus, a skin condition causing plaques and hair loss.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Some children with COVID-19 develop skin symptoms linked to a severe inflammatory condition.

High-dose methotrexate can cause severe skin and nail issues.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Bortezomib chemotherapy can cause temporary skin rashes.

Dermoscopy can help diagnose oral lichen planus by identifying specific patterns.

Cancer treatments often cause skin, nail, and hair problems.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

The patient improved after antiviral treatment for a viral infection.

Chemotherapy often causes hair loss, mouth sores, and dry skin.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.